Drug intelligence / Profile preview

StroMed + platelet rich plasma

Development stage
Preclinical
Lead developer
VivaTech
Modality
Patient-derived iPSCs → iPSCs → Pluripotent Stem Cells → Stem Cell Therapies → Cell Therapies, Hematopoietic Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies, Autologous CAR-T → CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, Mesenchymal Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies, Other Cell Types → Cell Therapies, Tumor-Infiltrating Lymphocytes (TILs) → Native Immune Cells → Adoptive Cell Transfer → Cell Therapies
Administration
Intraarticular, Intralesional, Intradermal, Subcutaneous, Topical
01

Overview

StroMed + platelet rich plasma is a combination regenerative therapy that merges two distinct biologic modalities: - **StroMed** typically refers to a proprietary preparation of stromal vascular fraction (SVF) derived from adipose (fat) tissue. SVF contains a heterogeneous mix of cells including mesenchymal stem cells, endothelial progenitor cells, pericytes, and immune cells. These components are thought to contribute to tissue repair through paracrine signaling, immunomodulation, angiogenesis promotion, and direct differentiation into target tissues. - **Platelet-rich plasma (PRP)** is an autologous blood product created by centrifuging the patient’s own blood to concentrate platelets in the plasma. Platelets release growth factors and cytokines that stimulate healing responses in damaged tissues[1][2][5]. PRP is widely used for musculoskeletal injuries, osteoarthritis, wound healing support after trauma or surgery[1][2][6], as well as for dermatologic applications such as hair loss[2]. The combination aims to synergize the regenerative potential of both cell-based therapy (from SVF/StroMed) and growth factor–rich biologics (from PRP), potentially enhancing tissue repair beyond what either component achieves alone.

Brand names
StroMed + platelet rich plasma
Other names
StroMed and PRPStroMed plus PRPStromed combined with platelet-rich plasma

Beyond the preview

Go deeper on StroMed + platelet rich plasma.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on StroMed + platelet rich plasma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call